Obesity Mediates Diabetes Risk Associated With Cholesterol-Lowering Therapy
Increased type 2 diabetes risk has been observed with cholesterol-lowering drugs and may be mediated by increased body mass index. Investigators examined the link.
Increased type 2 diabetes risk has been observed with cholesterol-lowering drugs and may be mediated by increased body mass index. Investigators examined the link.
Visceral fat predictive of carotid-femoral pulse wave velocity beyond body mass index and waist circumference
Approximately 5% to 10% of shift workers, including many health care professionals, suffer from shift work disorder, a circadian sleep-wake cycle disorder defined by poor quality sleep.
Current evidence is inadequate for assessing benefits and harms of type 2 diabetes screening in children and adolescents
Risk factors include older age, male sex, weight gain ≥10 kg since age 20 years, smoking, slow walking, quick eating, greater alcohol consumption
Estimated costs comparable to 1.8 percent of GDP across eight countries in 2019; economic impact projected to increase to 3.6 percent by 2060.
Obesity is caused by an imbalance of calories consumed vs calories expended, but researchers say there are additional risk factors at work as well.
Efruxifermin is a differentiated Fc-FGF21 fusion protein designed to mimic the biological activity of fibroblast growth factor 21.
Intermittent fasting can be safe and effective for glycemic control in patients with type 2 diabetes or metabolic syndrome, according to research results published in Diabetes Research and Clinical Practice.
Larger body size during childhood was found to have direct causal effect on CVD outcomes in adulthood.